Literature DB >> 3308227

Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis.

G Lüdemann1, W L Gross.   

Abstract

Autoantibodies against cytoplasmic components of neutrophil granulocytes (ACPA) were detected in 18 of 32 patients with Wegener's granulomatosis (WG), but in none of the controls (n = 900), including patients with glomerulonephritis, sarcoidosis, tuberculosis, polyarteritis nodosa, and connective tissue diseases, and healthy blood donors. The presence and, to a lesser extent, the titre of ACPA correlated with the severity and activity of the disease. ACPA could be detected in only three of 11 patients with the limited form of the disease and in none in complete remission. In contrast, in all patients with active extensive disease, ACPA were present in a higher titre, and in most of the patients in partial remission (eight of 12) antibodies were demonstrable, especially in those with frequent relapses. Furthermore, the antibody titre correlated significantly with the C-reactive protein concentration (P less than 0.05), but with none of the other laboratory parameters. In conclusion, ACPA have proven to be a highly specific disease marker of great clinical significance that provides us with a useful tool to confirm, or even establish. the diagnosis of WG.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308227      PMCID: PMC1542420     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.

Authors:  A S Fauci; B Haynes; P Katz
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

2.  Anticytoplasmic antibodies in Wegener's granulomatosis.

Authors:  W L Gross; G Lüdemann; G Kiefer; H Lehmann
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

3.  Anticytoplasmic antibodies in Wegener's granulomatosis.

Authors:  C R Hind; M B Pepys
Journal:  Lancet       Date:  1985-06-08       Impact factor: 79.321

4.  Objective monitoring of activity in Wegener's granulomatosis by measurement of serum C-reactive protein concentration.

Authors:  C R Hind; C G Winearls; C M Lockwood; A J Rees; M B Pepys
Journal:  Clin Nephrol       Date:  1984-06       Impact factor: 0.975

5.  SSA (Ro)-antibodies in Wegener's granulomatosis.

Authors:  K Andrassy; G Darai; J Koderisch; E Ritz
Journal:  Klin Wochenschr       Date:  1983-09-01

6.  Immunoregulation in autoimmunity.

Authors:  A S Fauci
Journal:  J Allergy Clin Immunol       Date:  1980-07       Impact factor: 10.793

7.  Acetylcholine receptor antibody in the diagnosis of myasthenia gravis.

Authors:  G A Nicholson; J G McLeod; L R Griffiths
Journal:  Med J Aust       Date:  1983-10-01       Impact factor: 7.738

Review 8.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Authors:  A S Fauci; B F Haynes; P Katz; S M Wolff
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

9.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

10.  Immunologic mechanisms in systemic vasculitis.

Authors:  D L Conn; F C McDuffie; K E Holley; A L Schroeter
Journal:  Mayo Clin Proc       Date:  1976-08       Impact factor: 7.616

  10 in total
  26 in total

Review 1.  The current status of neutrophil cytoplasmic antibodies.

Authors:  F J van der Woude; M R Daha; L A van Es
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

Review 2.  Significance of antibodies to cytoplasmic components of neutrophils.

Authors:  U Specks; R A DeRemee
Journal:  Thorax       Date:  1989-05       Impact factor: 9.139

3.  Antibodies to neutrophil cytoplasmic antigens in Wegener's granulomatosis and other conditions.

Authors:  D J Harrison; R Simpson; R Kharbanda; V E Abernethy; G Nimmo
Journal:  Thorax       Date:  1989-05       Impact factor: 9.139

4.  Antineutrophil cytoplasm antibodies in Kawasaki disease.

Authors:  C O Savage; J Tizard; D Jayne; C M Lockwood; M J Dillon
Journal:  Arch Dis Child       Date:  1989-03       Impact factor: 3.791

5.  Comparison of immunofluorescence and an immunohistochemical technique for the detection of perinuclear anti-neutrophil cytoplasmic antibody.

Authors:  A M McKane; S A McMillan; S K Conlan; T A McNeill
Journal:  Ir J Med Sci       Date:  1991-03       Impact factor: 1.568

Review 6.  Antineutrophil cytoplasmic antibody--a useful serological marker for vasculitis.

Authors:  J A Goeken
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

7.  Simplified method of preparing neutrophil slides to examine antibodies to cytoplasmic antigens.

Authors:  D E Roberts; C Peebles; R Daggett
Journal:  J Clin Pathol       Date:  1990-01       Impact factor: 3.411

Review 8.  Wegener's granulomatosis. Thoughts and observations of a pathologist.

Authors:  F Wegener
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

Review 9.  Anti-neutrophil cytoplasmic antibodies and vasculitis.

Authors:  B Leaker; G Cambridge
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

Review 10.  Assessment of disease activity in systemic vasculitis.

Authors:  W Y Tse; P Cockwell; C O Savage
Journal:  Postgrad Med J       Date:  1998-01       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.